MAB21L3: A Potential Drug Target and Biomarker (G126868)

Target Name: MAB21L3

NCBI ID: G126868

MAB21L3

MAB21L3: A Potential Drug Target and Biomarker

MAB21L3, also known as protein mab-21-like 3, is a protein that is expressed in various tissues and organs, including the brain, pancreas, and gastrointestinal tract. It is a member of the mab-21 family of proteins, which are known for their ability to interact with microtubules in cells. While the exact function of MAB21L3 is not yet fully understood, research has suggested that it may be involved in a variety of biological processes, including cell signaling, migration, and the regulation of ion channels.

One of the key features of MAB21L3 is its ability to interact with microtubules. These microtubules are dynamic structures that play a critical role in the regulation of cell behavior, including the transport of molecules to and from the cell surface and the control of cell division. MAB21L3 has been shown to interact with the protein tau, which is a microtubule-associated protein that is involved in the regulation of multiple cellular processes, including cell signaling and stress resistance.

The interaction between MAB21L3 and tau raises the possibility that MAB21L3 may be a drug target or biomarker for the treatment of various diseases. For example, MAB21L3 has been shown to be overexpressed in a variety of cancer types, including breast, ovarian, and colorectal cancer. Additionally, MAB21L3 has been shown to contribute to the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its potential as a drug target or biomarker, MAB21L3 also has interesting biological insights. The regulation of microtubules is a critical process that is involved in the development and maintenance of cellular organization and structure. MAB21L3's interaction with tau suggests that it may be involved in the regulation of microtubule dynamics and stability. This may have implications for the understanding and treatment of various diseases, including neurodegenerative diseases.

In conclusion, MAB21L3 is a protein that has raised the potential as a drug target or biomarker for the treatment of various diseases. Its interaction with microtubules and its expression in various tissues suggest that it may be involved in the regulation of multiple cellular processes, including cell signaling, migration, and the regulation of ion channels. Further research is needed to fully understand the function and potential of MAB21L3 in disease.

Protein Name: Mab-21 Like 3

The "MAB21L3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAB21L3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets